Results 161 to 170 of about 11,348,603 (380)
Another cartoon portrait of the mind from the reductionist metaphysicians--a review of Peter Carruthers ‘The Opacity of Mind’ (2011) (review revised 2019) [PDF]
Materialism, reductionism, behaviorism, functionalism, dynamic systems theory and computationalism are popular views, but they were shown by Wittgenstein to be incoherent.
Starks, Michael
core
Aim: This study aimed to compare the effectiveness of GI, NLP, and conventional behavioural management techniques in reducing dental anxiety among children aged 6–13 years receiving local anaesthesia.
Geetanjali Jadhav+4 more
doaj +1 more source
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková+14 more
wiley +1 more source
Group behavioral therapy of obsessive-compulsive disorder: Seven- vs. twelve-week outcomes [PDF]
Joseph A. Himle+5 more
+4 more sources
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim+11 more
wiley +1 more source
Excerpt: Aversion therapy uses a number of techniques and stimuli to weaken or eliminate undesirable responses such as deviant sexual behavior and substance abuse.
Bufford, Rodger K.
core
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez+5 more
wiley +1 more source